Erlotinib Completed Phase 1 Trials for Advanced Solid Tumors Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00139620A Pharmacokinetic Study of Erlotinib in Cancer Patients With Advanced Solid Tumors, With Adequate and Moderately Impaired Hepatic Function
NCT01472016Study of ABT-700 in Subjects With Advanced Solid Tumors
NCT00603356Phase I Study of OSI-930 and Erlotinib in Cancer Tumors
NCT00739453A Phase 1 Dose-escalation Study of OSI-906 and Erlotinib (Tarceva®)